drugset / Trial / NCT02176291
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
RandomizedParallel-groupTriple-blindTreatment
Summary
The purposes of this project are to examine the feasibility, safety, tolerability and clinical effect of low-dose buprenorphine as a novel treatment for late-life treatment-resistant depression and to develop preliminary data about mechanism of action.
Timeline
- Start
- 2014-08
- Primary completion
- 2017-04
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 0.2 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 2 mg | Other |